According to research published in the latest issue of Nature Genetics, more genetic markers useful in detecting Alzheimer’s Disease have been found, increasing the number of markers from five to ten. The recent success of this latest research is partly attributed to the combined data of the newly-formed International Genomics of Alzheimer’s Project (IGAP), a consortium of Alzheimer’s researchers from around the world.
While researchers are a long way from finding a cure, the IGAP makes it possible for them to use larger study samples and explore new theories for treatment. Current treatment largely focuses on deposits and plaque within the brain, but newer theories involving the properties of Alzheimer’s as an autoimmune disease and the metabolism of cholesterol are receiving attention from scientists.
The Alzheimer’s Association estimates that the number of Americans with Alzheimer’s Disease is around 5.2 million and that this number will increase to 16 million by 2050. If you or a loved one is experiencing any signs of Alzheimer’s Disease, please see your doctor for a diagnosis or to rule it out. An early diagnosis provides the opportunity to receive treatment and to plan for the future. For questions about Alzheimer’s Disease, the Alzheimer’s Association can be contacted at 877-474-8259 or visit their website at www.alz.org.
Early detection of Alzheimers will enable you to take care of your affairs and plan for your care. Long term care insurance, medicaid trusts, a power of attorney, health care proxy, and wills are some vehicles you can use to ensure your wishes will be followed if later you are unable to care for yourself and to help ensure financial stability of you and your family if you need long term care.
Please contact The Law Office of Erin McBee for assistance with your or a loved one’s planning at 978-257-5169 or e-mail: Erin@LawOfficeofErinMcBee.com